Status:
COMPLETED
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
Lead Sponsor:
Prostate Oncology Specialists, Inc.
Conditions:
Prostate Cancer
Castrate Resistant Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE1
Brief Summary
This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced p...
Eligibility Criteria
Inclusion
- Subjects with advanced prostate cancer who are eligible to receive sipuleucel-T in accordance with FDA approved labeling of sipuleucel-T
- Subjects must understand and sign an informed consent form
Exclusion
- Subjects who are not eligible to receive sipuleucel-T
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01832870
Start Date
April 1 2013
End Date
February 1 2016
Last Update
August 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prostate Oncology Specialists, Inc.
Marina del Rey, California, United States, 90292